Stefano Colagrande
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Use of DwI-MR to Predict Chemotherapy Response of Liver Metastases and Hepatocarcinoma (NCT01411579) | Stefano Colagrande | 2011-02-01 |
Track Stefano Colagrande automatically
Every clearance here is in the API, with alerts when new ones post.